Effect of new combined medication Young Prostate on clinical symptoms in patients with benign prostate hypertrophy and overactive bladder

Phase 3

Recruiting

• Conditions: Benign prostate hypertrophy.; Benign neoplasm of prostate; D29.1

• Registration Number: IRCT20120215009014N386
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 64

Inclusion Criteria

Age of 40 to 65 years
Benign prostate hypertrophy
Overactive bladder

Exclusion Criteria

History of prostate surgery

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sexual desire. Timepoint: Before the intervention and 3 and 6 months after that. Method of measurement: By taking history.;Prostate size. Timepoint: Before the intervention and 3 and 6 months after that. Method of measurement: Using ultrasonography.